rs1058945

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001106.4(ACVR2B):​c.*7688G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 152,208 control chromosomes in the GnomAD database, including 16,258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 16199 hom., cov: 32)
Exomes 𝑓: 0.51 ( 59 hom. )

Consequence

ACVR2B
NM_001106.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0220

Publications

19 publications found
Variant links:
Genes affected
ACVR2B (HGNC:174): (activin A receptor type 2B) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]
ACVR2B Gene-Disease associations (from GenCC):
  • heterotaxy, visceral, 4, autosomal
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 3-38491020-G-A is Benign according to our data. Variant chr3-38491020-G-A is described in ClinVar as Benign. ClinVar VariationId is 345025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVR2BNM_001106.4 linkc.*7688G>A 3_prime_UTR_variant Exon 11 of 11 ENST00000352511.5 NP_001097.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVR2BENST00000352511.5 linkc.*7688G>A 3_prime_UTR_variant Exon 11 of 11 1 NM_001106.4 ENSP00000340361.3

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
64856
AN:
151662
Hom.:
16200
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.179
Gnomad AMI
AF:
0.465
Gnomad AMR
AF:
0.388
Gnomad ASJ
AF:
0.493
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.510
Gnomad FIN
AF:
0.533
Gnomad MID
AF:
0.478
Gnomad NFE
AF:
0.573
Gnomad OTH
AF:
0.449
GnomAD4 exome
AF:
0.509
AC:
218
AN:
428
Hom.:
59
Cov.:
0
AF XY:
0.523
AC XY:
134
AN XY:
256
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.512
AC:
216
AN:
422
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.427
AC:
64858
AN:
151780
Hom.:
16199
Cov.:
32
AF XY:
0.425
AC XY:
31509
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.178
AC:
7366
AN:
41308
American (AMR)
AF:
0.387
AC:
5916
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.493
AC:
1711
AN:
3470
East Asian (EAS)
AF:
0.269
AC:
1388
AN:
5152
South Asian (SAS)
AF:
0.510
AC:
2454
AN:
4808
European-Finnish (FIN)
AF:
0.533
AC:
5603
AN:
10512
Middle Eastern (MID)
AF:
0.480
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
0.573
AC:
38910
AN:
67952
Other (OTH)
AF:
0.449
AC:
947
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1670
3340
5009
6679
8349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.509
Hom.:
27456
Bravo
AF:
0.400
Asia WGS
AF:
0.401
AC:
1393
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Heterotaxy, visceral, 4, autosomal Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
3.1
DANN
Benign
0.77
PhyloP100
-0.022
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1058945; hg19: chr3-38532511; API